�ݺ�ߣshows by User: tushardm

�ݺ�ߣshows by User: tushardm / http://www.slideshare.net/images/logo.gif �ݺ�ߣshows by User: tushardm / Tue, 19 Dec 2023 09:01:14 GMT �ݺ�ߣShare feed for �ݺ�ߣshows by User: tushardm Anesthesia, Types of anesthesia, with Pharmacology /tushardm/anesthesia-types-of-anesthesia-with-pharmacology anesthesia-231219090114-e40db018
Anesthesia, Types of anesthesia, with Pharmacology]]>
Anesthesia, Types of anesthesia, with Pharmacology]]> Tue, 19 Dec 2023 09:01:14 GMT /tushardm/anesthesia-types-of-anesthesia-with-pharmacology tushardm@slideshare.net(tushardm) Anesthesia, Types of anesthesia, with Pharmacology tushardm Anesthesia, Types of anesthesia, with Pharmacology <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/anesthesia-231219090114-e40db018-thumbnail.jpg?width=120&height=120&fit=bounds" /> Anesthesia, Types of anesthesia, with Pharmacology

Anesthesia, Types of anesthesia, with Pharmacology from Tushar Morankar

]]> 541 0 https://cdn.slidesharecdn.com/ss_thumbnails/anesthesia-231219090114-e40db018-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Study of cloning vectors, restriction endonucleases and DNA ligase. /slideshow/study-of-cloning-vectors-restriction-endonucleases-and-dna-ligase/220888208 unitiia-200117080529
Study of cloning vectors, restriction endonucleases and DNA ligase. *CLONING VECTOR Types of Cloning Vectors 1.Plasmids 2.Bateriophages 3.Phasmids 4.Cosmids 5.Artificial chromosomes 6.BACs 7.YACs 8.HACs 9.Retroviral *Restriction endonucleases *DNA ligase ]]>
Study of cloning vectors, restriction endonucleases and DNA ligase. *CLONING VECTOR Types of Cloning Vectors 1.Plasmids 2.Bateriophages 3.Phasmids 4.Cosmids 5.Artificial chromosomes 6.BACs 7.YACs 8.HACs 9.Retroviral *Restriction endonucleases *DNA ligase ]]> Fri, 17 Jan 2020 08:05:29 GMT /slideshow/study-of-cloning-vectors-restriction-endonucleases-and-dna-ligase/220888208 tushardm@slideshare.net(tushardm) Study of cloning vectors, restriction endonucleases and DNA ligase. tushardm Study of cloning vectors, restriction endonucleases and DNA ligase. *CLONING VECTOR Types of Cloning Vectors 1.Plasmids 2.Bateriophages 3.Phasmids 4.Cosmids 5.Artificial chromosomes 6.BACs 7.YACs 8.HACs 9.Retroviral *Restriction endonucleases *DNA ligase <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/unitiia-200117080529-thumbnail.jpg?width=120&height=120&fit=bounds" /> Study of cloning vectors, restriction endonucleases and DNA ligase. *CLONING VECTOR Types of Cloning Vectors 1.Plasmids 2.Bateriophages 3.Phasmids 4.Cosmids 5.Artificial chromosomes 6.BACs 7.YACs 8.HACs 9.Retroviral *Restriction endonucleases *DNA ligase

Study of cloning vectors, restriction endonucleases and DNA ligase. from Tushar Morankar

]]> 29643 3 https://cdn.slidesharecdn.com/ss_thumbnails/unitiia-200117080529-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 The Drugs and Magic Remedies Act 1955 /slideshow/the-drugs-and-magic-remedies-act-1955/184050484 dmr-191019111138
India is the land of spiritualist of babas and sadhus. There has not been a law specifically to prosecute those making false spiritual claims and deceive people. ]]>
India is the land of spiritualist of babas and sadhus. There has not been a law specifically to prosecute those making false spiritual claims and deceive people. ]]> Sat, 19 Oct 2019 11:11:38 GMT /slideshow/the-drugs-and-magic-remedies-act-1955/184050484 tushardm@slideshare.net(tushardm) The Drugs and Magic Remedies Act 1955 tushardm India is the land of spiritualist of babas and sadhus. There has not been a law specifically to prosecute those making false spiritual claims and deceive people. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/dmr-191019111138-thumbnail.jpg?width=120&height=120&fit=bounds" /> India is the land of spiritualist of babas and sadhus. There has not been a law specifically to prosecute those making false spiritual claims and deceive people.

The Drugs and Magic Remedies Act 1955 from Tushar Morankar

]]> 890 0 https://cdn.slidesharecdn.com/ss_thumbnails/dmr-191019111138-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 National pharmaceutical pricing authority with drugs price control order (dpco)2013 /slideshow/national-pharmaceutical-pricing-authority-with-drugs-price-control-order-dpco2013/183122423 nationalpharmaceuticalpricingauthoritywithdrugspricecontrolorderdpco2013-191017120828
The government has notified the DPCO 2013 under the Essential Commodities Act, 1955, which will give power to the NPPA (National Pharmaceutical Pricing Authority (NPPA )to regulate prices of 348 essential drugs along with their specified strengths and dosages under NLEM 2011. Main Features of the DPCO 2013 • The new order will bring 348 drugs & their 652 formulations under price control. • The new policy uses a market-based pricing mechanism against the earlier proposed cost-plus method. The ceiling price would be calculated by taking the simple average of prices of all brands of a drug with a market share of 1% or more.]]>
The government has notified the DPCO 2013 under the Essential Commodities Act, 1955, which will give power to the NPPA (National Pharmaceutical Pricing Authority (NPPA )to regulate prices of 348 essential drugs along with their specified strengths and dosages under NLEM 2011. Main Features of the DPCO 2013 • The new order will bring 348 drugs & their 652 formulations under price control. • The new policy uses a market-based pricing mechanism against the earlier proposed cost-plus method. The ceiling price would be calculated by taking the simple average of prices of all brands of a drug with a market share of 1% or more.]]> Thu, 17 Oct 2019 12:08:28 GMT /slideshow/national-pharmaceutical-pricing-authority-with-drugs-price-control-order-dpco2013/183122423 tushardm@slideshare.net(tushardm) National pharmaceutical pricing authority with drugs price control order (dpco)2013 tushardm The government has notified the DPCO 2013 under the Essential Commodities Act, 1955, which will give power to the NPPA (National Pharmaceutical Pricing Authority (NPPA )to regulate prices of 348 essential drugs along with their specified strengths and dosages under NLEM 2011. Main Features of the DPCO 2013 • The new order will bring 348 drugs & their 652 formulations under price control. • The new policy uses a market-based pricing mechanism against the earlier proposed cost-plus method. The ceiling price would be calculated by taking the simple average of prices of all brands of a drug with a market share of 1% or more. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/nationalpharmaceuticalpricingauthoritywithdrugspricecontrolorderdpco2013-191017120828-thumbnail.jpg?width=120&height=120&fit=bounds" /> The government has notified the DPCO 2013 under the Essential Commodities Act, 1955, which will give power to the NPPA (National Pharmaceutical Pricing Authority (NPPA )to regulate prices of 348 essential drugs along with their specified strengths and dosages under NLEM 2011. Main Features of the DPCO 2013 • The new order will bring 348 drugs & their 652 formulations under price control. • The new policy uses a market-based pricing mechanism against the earlier proposed cost-plus method. The ceiling price would be calculated by taking the simple average of prices of all brands of a drug with a market share of 1% or more.

National pharmaceutical pricing authority with drugs price control order (dpco)2013 from Tushar Morankar

]]> 13559 2 https://cdn.slidesharecdn.com/ss_thumbnails/nationalpharmaceuticalpricingauthoritywithdrugspricecontrolorderdpco2013-191017120828-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Congestive heart failure (chf) medicinal chemistry /slideshow/congestive-heart-failure-chf-medicinal-chemistry/183121601 congestiveheartfailurechfmedicinalchemistry-191017120409
A condition in which the heart is unable to pump sufficient blood to meet the metabolic demand of the body and also unable to receive it back because every time after a systole.]]>
A condition in which the heart is unable to pump sufficient blood to meet the metabolic demand of the body and also unable to receive it back because every time after a systole.]]> Thu, 17 Oct 2019 12:04:09 GMT /slideshow/congestive-heart-failure-chf-medicinal-chemistry/183121601 tushardm@slideshare.net(tushardm) Congestive heart failure (chf) medicinal chemistry tushardm A condition in which the heart is unable to pump sufficient blood to meet the metabolic demand of the body and also unable to receive it back because every time after a systole. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/congestiveheartfailurechfmedicinalchemistry-191017120409-thumbnail.jpg?width=120&height=120&fit=bounds" /> A condition in which the heart is unable to pump sufficient blood to meet the metabolic demand of the body and also unable to receive it back because every time after a systole.

Congestive heart failure (chf) medicinal chemistry from Tushar Morankar

]]> 15424 1 https://cdn.slidesharecdn.com/ss_thumbnails/congestiveheartfailurechfmedicinalchemistry-191017120409-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Drug price control order 2013 /slideshow/drug-price-control-order-2013-178943385/178943385 drugpricecontrolorder2013-191004021130
The government has notified the DPCO 2013 under the Essential Commodities Act, 1955, which will give power to the NPPA (National Pharmaceutical Pricing Authority (NPPA )to regulate prices of 348 essential drugs along with their specified strengths and dosages under NLEM 2011. ]]>
The government has notified the DPCO 2013 under the Essential Commodities Act, 1955, which will give power to the NPPA (National Pharmaceutical Pricing Authority (NPPA )to regulate prices of 348 essential drugs along with their specified strengths and dosages under NLEM 2011. ]]> Fri, 04 Oct 2019 02:11:30 GMT /slideshow/drug-price-control-order-2013-178943385/178943385 tushardm@slideshare.net(tushardm) Drug price control order 2013 tushardm The government has notified the DPCO 2013 under the Essential Commodities Act, 1955, which will give power to the NPPA (National Pharmaceutical Pricing Authority (NPPA )to regulate prices of 348 essential drugs along with their specified strengths and dosages under NLEM 2011. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/drugpricecontrolorder2013-191004021130-thumbnail.jpg?width=120&height=120&fit=bounds" /> The government has notified the DPCO 2013 under the Essential Commodities Act, 1955, which will give power to the NPPA (National Pharmaceutical Pricing Authority (NPPA )to regulate prices of 348 essential drugs along with their specified strengths and dosages under NLEM 2011.

Drug price control order 2013 from Tushar Morankar

]]> 34111 4 https://cdn.slidesharecdn.com/ss_thumbnails/drugpricecontrolorder2013-191004021130-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Cell cycle and regulation /slideshow/cell-cycle-and-regulation-174759738/174759738 cellcycleandregulation-190922111716
Cell cycle and Regulation * cell Division is occur in every human but these have certaint check point to preventing from the forming the defective cell or cancerious cell.]]>
Cell cycle and Regulation * cell Division is occur in every human but these have certaint check point to preventing from the forming the defective cell or cancerious cell.]]> Sun, 22 Sep 2019 11:17:16 GMT /slideshow/cell-cycle-and-regulation-174759738/174759738 tushardm@slideshare.net(tushardm) Cell cycle and regulation tushardm Cell cycle and Regulation * cell Division is occur in every human but these have certaint check point to preventing from the forming the defective cell or cancerious cell. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/cellcycleandregulation-190922111716-thumbnail.jpg?width=120&height=120&fit=bounds" /> Cell cycle and Regulation * cell Division is occur in every human but these have certaint check point to preventing from the forming the defective cell or cancerious cell.

Cell cycle and regulation from Tushar Morankar

]]> 23120 3 https://cdn.slidesharecdn.com/ss_thumbnails/cellcycleandregulation-190922111716-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 DRUGS AND COSMETICS ACT 1940 AND RULES THEIR UNDER 1945 SCHEDULE M. /slideshow/drugs-and-cosmetics-act-1940-and-rules-their-under-1945-schedule-m/161234736 schedulemrcp-converted-190805142936
DRUGS AND COSMETICS ACT 1940 AND RULES THEIR UNDER 1945 SCHEDULE M. BY: Mr.Tushar D. Morankar RCPIPER, Shirpur MH425405]]>
DRUGS AND COSMETICS ACT 1940 AND RULES THEIR UNDER 1945 SCHEDULE M. BY: Mr.Tushar D. Morankar RCPIPER, Shirpur MH425405]]> Mon, 05 Aug 2019 14:29:36 GMT /slideshow/drugs-and-cosmetics-act-1940-and-rules-their-under-1945-schedule-m/161234736 tushardm@slideshare.net(tushardm) DRUGS AND COSMETICS ACT 1940 AND RULES THEIR UNDER 1945 SCHEDULE M. tushardm DRUGS AND COSMETICS ACT 1940 AND RULES THEIR UNDER 1945 SCHEDULE M. BY: Mr.Tushar D. Morankar RCPIPER, Shirpur MH425405 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/schedulemrcp-converted-190805142936-thumbnail.jpg?width=120&height=120&fit=bounds" /> DRUGS AND COSMETICS ACT 1940 AND RULES THEIR UNDER 1945 SCHEDULE M. BY: Mr.Tushar D. Morankar RCPIPER, Shirpur MH425405

DRUGS AND COSMETICS ACT 1940 AND RULES THEIR UNDER 1945 SCHEDULE M. from Tushar Morankar

]]> 1382 31 https://cdn.slidesharecdn.com/ss_thumbnails/schedulemrcp-converted-190805142936-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Drugs and Cosmetics Act 1940 And Their Under 1945 /tushardm/drugs-and-cosmetics-act-1940-159400209 final-190731125125
Specifically Disscussed about Schedule U &V]]>
Specifically Disscussed about Schedule U &V]]> Wed, 31 Jul 2019 12:51:25 GMT /tushardm/drugs-and-cosmetics-act-1940-159400209 tushardm@slideshare.net(tushardm) Drugs and Cosmetics Act 1940 And Their Under 1945 tushardm Specifically Disscussed about Schedule U &V <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/final-190731125125-thumbnail.jpg?width=120&height=120&fit=bounds" /> Specifically Disscussed about Schedule U &V

Drugs and Cosmetics Act 1940 And Their Under 1945 from Tushar Morankar

]]> 448 4 https://cdn.slidesharecdn.com/ss_thumbnails/final-190731125125-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Souvenir RTHDT 2018 /slideshow/souvenir-rthdt-2018/157581845 souvenirrthdt2018-190724171916
Trabactine : A Lead for Anti-cancer Abstract: Marine secondary metabolites are a promising source of unexploited drugs that have a wide structural diversity and have shown a variety of biological activities. These compounds are produced in response to the harsh and competitive conditions that occur in the marine environment. Invertebrates are considered to be among the groups with the richest biodiversity. To date, a significant number of marine natural products (MNPs) have been established as antineoplastic drugs. This review gives an overview of MNPs, both in research or clinical stages, from diverse organisms that were reported as being active or potentially active in cancer treatment in the past seventeen years (from January 2000 until April 2017) and describes their putative mechanisms of action. The structural diversity of MNPs is also highlighted and compared with the small-molecule anticancer drugs in clinical use. In addition, this review examines the use of virtual screening for MNP-based drug discovery and reveals that classical approaches for the selection of drug candidates based on ADMET (absorption, distribution, metabolism, excretion, and toxicity) filtering may miss potential anticancer lead compounds. Finally, we introduce a novel and publically accessible chemical library of MNPs for virtual screening purposes. Keywords: marine natural product; invertebrate; cancer; virtual screeni in trabactine]]>
Trabactine : A Lead for Anti-cancer Abstract: Marine secondary metabolites are a promising source of unexploited drugs that have a wide structural diversity and have shown a variety of biological activities. These compounds are produced in response to the harsh and competitive conditions that occur in the marine environment. Invertebrates are considered to be among the groups with the richest biodiversity. To date, a significant number of marine natural products (MNPs) have been established as antineoplastic drugs. This review gives an overview of MNPs, both in research or clinical stages, from diverse organisms that were reported as being active or potentially active in cancer treatment in the past seventeen years (from January 2000 until April 2017) and describes their putative mechanisms of action. The structural diversity of MNPs is also highlighted and compared with the small-molecule anticancer drugs in clinical use. In addition, this review examines the use of virtual screening for MNP-based drug discovery and reveals that classical approaches for the selection of drug candidates based on ADMET (absorption, distribution, metabolism, excretion, and toxicity) filtering may miss potential anticancer lead compounds. Finally, we introduce a novel and publically accessible chemical library of MNPs for virtual screening purposes. Keywords: marine natural product; invertebrate; cancer; virtual screeni in trabactine]]> Wed, 24 Jul 2019 17:19:16 GMT /slideshow/souvenir-rthdt-2018/157581845 tushardm@slideshare.net(tushardm) Souvenir RTHDT 2018 tushardm Trabactine : A Lead for Anti-cancer Abstract: Marine secondary metabolites are a promising source of unexploited drugs that have a wide structural diversity and have shown a variety of biological activities. These compounds are produced in response to the harsh and competitive conditions that occur in the marine environment. Invertebrates are considered to be among the groups with the richest biodiversity. To date, a significant number of marine natural products (MNPs) have been established as antineoplastic drugs. This review gives an overview of MNPs, both in research or clinical stages, from diverse organisms that were reported as being active or potentially active in cancer treatment in the past seventeen years (from January 2000 until April 2017) and describes their putative mechanisms of action. The structural diversity of MNPs is also highlighted and compared with the small-molecule anticancer drugs in clinical use. In addition, this review examines the use of virtual screening for MNP-based drug discovery and reveals that classical approaches for the selection of drug candidates based on ADMET (absorption, distribution, metabolism, excretion, and toxicity) filtering may miss potential anticancer lead compounds. Finally, we introduce a novel and publically accessible chemical library of MNPs for virtual screening purposes. Keywords: marine natural product; invertebrate; cancer; virtual screeni in trabactine <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/souvenirrthdt2018-190724171916-thumbnail.jpg?width=120&height=120&fit=bounds" /> Trabactine : A Lead for Anti-cancer Abstract: Marine secondary metabolites are a promising source of unexploited drugs that have a wide structural diversity and have shown a variety of biological activities. These compounds are produced in response to the harsh and competitive conditions that occur in the marine environment. Invertebrates are considered to be among the groups with the richest biodiversity. To date, a significant number of marine natural products (MNPs) have been established as antineoplastic drugs. This review gives an overview of MNPs, both in research or clinical stages, from diverse organisms that were reported as being active or potentially active in cancer treatment in the past seventeen years (from January 2000 until April 2017) and describes their putative mechanisms of action. The structural diversity of MNPs is also highlighted and compared with the small-molecule anticancer drugs in clinical use. In addition, this review examines the use of virtual screening for MNP-based drug discovery and reveals that classical approaches for the selection of drug candidates based on ADMET (absorption, distribution, metabolism, excretion, and toxicity) filtering may miss potential anticancer lead compounds. Finally, we introduce a novel and publically accessible chemical library of MNPs for virtual screening purposes. Keywords: marine natural product; invertebrate; cancer; virtual screeni in trabactine

Souvenir RTHDT 2018 from Tushar Morankar

]]> 71 5 https://cdn.slidesharecdn.com/ss_thumbnails/souvenirrthdt2018-190724171916-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Generic vs branded medicine /slideshow/generic-vs-branded-medicine/134079614 genericvsbrandedmedicine-190302080123
1.Patients have poor or no knowledge of the price variations among branded and generic medicines, and leave the choice of the medicine to the doctor. 2.The government must take up generic promotional schemes, general awareness programs on quality of generics to build confidence among prescribers, pharmacists, and consumers. ]]>
1.Patients have poor or no knowledge of the price variations among branded and generic medicines, and leave the choice of the medicine to the doctor. 2.The government must take up generic promotional schemes, general awareness programs on quality of generics to build confidence among prescribers, pharmacists, and consumers. ]]> Sat, 02 Mar 2019 08:01:23 GMT /slideshow/generic-vs-branded-medicine/134079614 tushardm@slideshare.net(tushardm) Generic vs branded medicine tushardm 1.Patients have poor or no knowledge of the price variations among branded and generic medicines, and leave the choice of the medicine to the doctor. 2.The government must take up generic promotional schemes, general awareness programs on quality of generics to build confidence among prescribers, pharmacists, and consumers. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/genericvsbrandedmedicine-190302080123-thumbnail.jpg?width=120&height=120&fit=bounds" /> 1.Patients have poor or no knowledge of the price variations among branded and generic medicines, and leave the choice of the medicine to the doctor. 2.The government must take up generic promotional schemes, general awareness programs on quality of generics to build confidence among prescribers, pharmacists, and consumers.

Generic vs branded medicine from Tushar Morankar

]]> 5611 4 https://cdn.slidesharecdn.com/ss_thumbnails/genericvsbrandedmedicine-190302080123-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 https://cdn.slidesharecdn.com/profile-photo-tushardm-48x48.jpg?cb=1712562064 MANY SKIILED REGARDING PROFESSIONAL PRESENTATIONS ... tmorankar.blogspot.com/ https://cdn.slidesharecdn.com/ss_thumbnails/anesthesia-231219090114-e40db018-thumbnail.jpg?width=320&height=320&fit=bounds tushardm/anesthesia-types-of-anesthesia-with-pharmacology Anesthesia, Types of a... https://cdn.slidesharecdn.com/ss_thumbnails/unitiia-200117080529-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/study-of-cloning-vectors-restriction-endonucleases-and-dna-ligase/220888208 Study of cloning vecto... https://cdn.slidesharecdn.com/ss_thumbnails/dmr-191019111138-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/the-drugs-and-magic-remedies-act-1955/184050484 The Drugs and Magic Re...